News - Townsend Investments
LATEST NEWS:
NovaBiotics News

Dr Deborah O'Neil will present data on Novamycin, a novel peptide antifungal intervention for clinically challenging mycoses in immunocompromised patients.

The 2016 Boul...

Read More

NOVABIOTICS "ONE TO WATCH" FOR 2017.

NovaBiotics has been shortlisted for Biotech & Money's 2016 Assembly & Awards Gala Dinner (to be held ...

Read More

NovaBiotics Ltd (‘NovaBiotics’ or the ‘Company’), the Aberdeen-based clinical-stage biotechnology company, has presented new data showing antibiotic resi...

Read More

NovaBiotics announces today that Principal Scientist, Dr Douglas Fraser-Pitt will be presenting new data on antibiotic resistance at ASM Microbe 2016, Boston, USA, 16-20 June.  

Dr Fra...

Read More